feed,title,long_url,short_url
SeekingAlpha,Dosing underway in Lexicon Pharma's mid-stage LX9211 study in diabetic neuropathic pain,https://seekingalpha.com/news/3611733,
SeekingAlpha,Gilead files supplemental U.S. application for expanded use of Yescarta,https://seekingalpha.com/news/3611732,
SeekingAlpha,Campbell Soup not appetizing yet to Wells Fargo,https://seekingalpha.com/news/3611731,
